ODI Pharma AB (publ) (NGM:ODI)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.000
+0.020 (0.67%)
At close: Jun 12, 2026
Market Cap54.99M +28.9%
Revenue (ttm)29.82M +182.1%
Net Income-362.67K
EPS-0.02
Shares Out 18.33M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume90
Open3.000
Previous Close2.980
Day's Range3.000 - 3.000
52-Week Range1.000 - 5.450
Beta0.81
Analystsn/a
Price Targetn/a
Earnings DateMay 28, 2026

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products. ODI Pharma AB (publ) was founded in 2018 and is based in Stockholm, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol ODI
Full Company Profile

Financial Performance

In fiscal year 2025, ODI Pharma AB's revenue was 3.13 million, a decrease of -85.94% compared to the previous year's 22.29 million. Losses were -5.93 million, 944.5% more than in 2024.

Financial Statements

News

ODI Pharma AB Quarterly report: Q3 2026

ODI Pharma AB has published its Q3 2026 quarterly earnings report on May 28, 2026.

18 days ago - Filings

ODI Pharma AB Quarterly report: Q2 2026

ODI Pharma AB has published its Q2 2026 quarterly earnings report on February 26, 2026.

3 months ago - Filings

ODI Pharma AB Quarterly report: Q1 2026

ODI Pharma AB has published its Q1 2026 quarterly earnings report on November 27, 2025.

7 months ago - Filings

ODI Pharma AB Annual report: Q4 2025

ODI Pharma AB has published its Q4 2025 annual report on August 28, 2025.

10 months ago - Filings

ODI Pharma AB Quarterly report: Q4 2025

ODI Pharma AB has published its Q4 2025 quarterly earnings report on August 28, 2025.

10 months ago - Filings